Enhanced Tuberculosis Case Detection Among Substitution Treatment Patients

Prevalence of Latent Tuberculosis and Enhanced Tuberculosis Case Detection Among Injecting Drug Users Receiving Methadone Substitution Treatment

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT01290081

Acronym

TBIDU

Enrollment

112

Registered

2011-02-04

Start date

2007-10-31

Completion date

2008-01-31

Last updated

2011-02-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tuberculosis

Keywords

Tuberculosis, Injecting drug users, Case management

Brief summary

The purpose of this study was to determine the prevalence of latent tuberculosis infection among injecting drug users and to conduct randomized controlled trial to evaluate a case management intervention aimed at increasing TB screening and treatment entry among injecting drug users referred from a methadone drug treatment program in Estonia.

Interventions

OTHERCase management approach in referral to health care services

Case management intervention aimed at increasing TB screening and treatment entry among injecting drug users referred from a methadone drug treatment program

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

HEALTH_SERVICES_RESEARCH

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Inclusion criteria

* Participation in substitution treatment program, * Age 18 years or more, * Able to read and write in Estonian or Russian, * Able to provide informed consent

Countries

Estonia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 28, 2026